SCOLR’s Extended-Release Ibuprofen Plans Ramp Up After Break With Wyeth
This article was originally published in The Tan Sheet
Executive Summary
SCOLR Pharma plans to submit a new drug application for its extended-release ibuprofen to FDA in the latter half of 2008
You may also be interested in...
SCOLR Expects New Licensing Agreement This Year
SCOLR Pharma says it could have a new licensing agreement for an extended release ibuprofen product made with its patented Controlled Delivery Technology by September of this year
SCOLR Expects New Licensing Agreement This Year
SCOLR Pharma says it could have a new licensing agreement for an extended release ibuprofen product made with its patented Controlled Delivery Technology by September of this year
SCOLR Expects New Licensing Agreement This Year
SCOLR Pharma says it could have a new licensing agreement for an extended release ibuprofen product made with its patented Controlled Delivery Technology by September of this year